These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6595259)

  • 21. Serum bactericidal activity against aerobes and anaerobes of volunteers receiving cefoxitin or cefotetan.
    Cruciani M; Navarra A; Bono L; Concia E
    Chemioterapia; 1988 Aug; 7(4):261-3. PubMed ID: 3180306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Annual incidence, epidemiology, and comparative in vitro susceptibilities to cefoxitin, cefotetan, cefmetazole, and ceftizoxime of recent community-acquired isolates of the Bacteroides fragilis group.
    Goldstein EJ; Citron DM
    J Clin Microbiol; 1988 Nov; 26(11):2361-6. PubMed ID: 3235664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the 10-micrograms clindamycin disk for susceptibility testing of anaerobes by the aerobically incubated thioglycolate broth disk method.
    Toohey KL; Kurzynski TA; Schell RF; Birk RJ; Zabransky RJ
    J Clin Microbiol; 1986 Mar; 23(3):619-21. PubMed ID: 3958150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cefoxitin in the treatment of aerobic and anaerobic infections. Prospective correlation of in vitro susceptibility methods with clinical outcome.
    Goldstein EJ; Citron DM; Cole RE; Rangel DM; Seid AS; Ostovari MO
    Hosp Pract (Off Ed); 1990 Oct; 25 Suppl 4():38-45. PubMed ID: 2120272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Broth-disk elution tests to predict the susceptibility of anaerobic bacteria to the ampicillin-sulbactam combination.
    Jones RN
    Diagn Microbiol Infect Dis; 1990; 13(4):353-5. PubMed ID: 2076598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of the in vitro activity of cefotetan on bacterial strains of recent hospital isolation].
    Lembo M; Nani E; Covelli I; Anzivino D; Gulletta E
    G Batteriol Virol Immunol; 1985; 78(7-12):224-44. PubMed ID: 3870426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Susceptibility of bacterial pathogens to cefotetan judged by MIC and disc tests.
    Grimm H
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():37-43. PubMed ID: 6573324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative antimicrobial activity of aminothiazolyl methoxyimino cephalosporins against anaerobic bacteria, including 100 cefoxitin-resistant isolates.
    Jones RN; Barry AL; Aldridge KE; Gerlach EH
    Diagn Microbiol Infect Dis; 1987 Nov; 8(3):157-63. PubMed ID: 3501976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of cephalosporins/cephamycins with antianaerobic activity by integrating microbiologic and pharmacokinetic properties.
    Kays MB; White RL; Friedrich LV; Del Bene VE
    Clin Ther; 1991; 13(5):596-605. PubMed ID: 1799917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of in-vitro activity of cefotetan (ICI 156834), a new cephamycin derivative, with that of cefoxitin.
    Chattopadhyay B; Teli JC
    J Antimicrob Chemother; 1982 Aug; 10(2):151-4. PubMed ID: 6956565
    [No Abstract]   [Full Text] [Related]  

  • 31. Susceptibility of cefotetan and Sch 34343 to beta-lactamases produced by strains of Bacteroides that hydrolyse cefoxitin or imipenem.
    Andrew JH; Greenwood D
    J Antimicrob Chemother; 1987 May; 19(5):591-5. PubMed ID: 3497146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of cefotetan, a new cephamycin derivative, compared with that of other beta-lactam compounds.
    Wise R; Andrews JM; Hancox J
    Antimicrob Agents Chemother; 1982 Mar; 21(3):486-91. PubMed ID: 6954875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cefotetan, an in vitro comparison with other antibiotics.
    Qadri SM; Belobraydic KA
    J Okla State Med Assoc; 1987 Apr; 80(4):232-5. PubMed ID: 3473192
    [No Abstract]   [Full Text] [Related]  

  • 34. Serum bactericidal activity against aerobes and anaerobes of volunteers receiving cefoxitin or cefotetan.
    Cruciani M; Navarra A; Bono L; Concia E
    J Chemother; 1989 Jul; 1(4 Suppl):101-2. PubMed ID: 16312323
    [No Abstract]   [Full Text] [Related]  

  • 35. In vitro activity of cefbuperazone, a new cephamycin, against anaerobic bacteria.
    Prabhala RH; Thadepalli H; Rao B; Bansal MB; Marshall R
    Antimicrob Agents Chemother; 1985 Apr; 27(4):640-2. PubMed ID: 4004195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative in vitro susceptibilities of anaerobic bacteria to cefmenoxime, cefotetan, and N-formimidoyl thienamycin.
    Owens WE; Finegold SM
    Antimicrob Agents Chemother; 1983 Apr; 23(4):626-9. PubMed ID: 6305265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the bactericidal activity of clindamycin and metronidazole against cefoxitin-susceptible and cefoxitin-resistant isolates of the Bacteroides fragilis group.
    Stratton CW; Weeks LS; Aldridge KE
    Diagn Microbiol Infect Dis; 1991; 14(5):377-82. PubMed ID: 1797454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cefoperazone and cefoperazone-sulbactam susceptibility tests with anaerobic bacteria by the thioglycolate disk elution method.
    Barry AL; Packer RR; Jones RN
    J Clin Microbiol; 1985 Nov; 22(5):882-3. PubMed ID: 2997274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative in vitro activity of cefoxitin vs. cefotetan against clinical isolates of Bacteroides and Prevotella species.
    Grossmeyer TJ; Farmer SG
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S353-6. PubMed ID: 8324146
    [No Abstract]   [Full Text] [Related]  

  • 40. Antimicrobial activity, beta-lactamase stability and beta-lactamase inhibition of cefotetan and other 7-alpha-methoxy beta-lactam antimicrobials.
    Jones RN; Wilson HW
    Diagn Microbiol Infect Dis; 1983 Mar; 1(1):71-83. PubMed ID: 6323095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.